CN111714625A - 杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法 - Google Patents
杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法 Download PDFInfo
- Publication number
- CN111714625A CN111714625A CN202010672273.6A CN202010672273A CN111714625A CN 111714625 A CN111714625 A CN 111714625A CN 202010672273 A CN202010672273 A CN 202010672273A CN 111714625 A CN111714625 A CN 111714625A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- helicobacter pylori
- killing
- oral cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000590002 Helicobacter pylori Species 0.000 title claims abstract description 48
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 48
- 210000000214 mouth Anatomy 0.000 title claims abstract description 36
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 31
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229940034610 toothpaste Drugs 0.000 claims abstract description 38
- 239000000606 toothpaste Substances 0.000 claims abstract description 38
- 239000011159 matrix material Substances 0.000 claims abstract description 29
- 229940075000 frankincense extract Drugs 0.000 claims abstract description 28
- 239000006072 paste Substances 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 23
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 21
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 21
- 102000016943 Muramidase Human genes 0.000 claims abstract description 21
- 108010014251 Muramidase Proteins 0.000 claims abstract description 21
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 21
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 21
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 21
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 21
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 21
- 229960000274 lysozyme Drugs 0.000 claims abstract description 21
- 239000004325 lysozyme Substances 0.000 claims abstract description 21
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000202726 Bupleurum Species 0.000 claims abstract description 19
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 19
- 244000286838 Eclipta prostrata Species 0.000 claims abstract description 19
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 19
- 241000334160 Isatis Species 0.000 claims abstract description 19
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 19
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 19
- 229940069521 aloe extract Drugs 0.000 claims abstract description 19
- 229960002684 aminocaproic acid Drugs 0.000 claims abstract description 19
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 19
- 235000011477 liquorice Nutrition 0.000 claims abstract description 19
- HTLBMAZNGBFLEY-UHFFFAOYSA-N stemonine-C17 Natural products O1C(=O)C(C)CC1C1N2CCCC3OC(=O)C(C)C3C2CC1 HTLBMAZNGBFLEY-UHFFFAOYSA-N 0.000 claims abstract description 19
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 18
- 239000013521 mastic Substances 0.000 claims abstract description 16
- 239000006071 cream Substances 0.000 claims abstract description 8
- 241001313855 Bletilla Species 0.000 claims abstract description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 35
- 238000010438 heat treatment Methods 0.000 claims description 21
- 241000723353 Chrysanthemum Species 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 241001313857 Bletilla striata Species 0.000 claims description 16
- 241000555712 Forsythia Species 0.000 claims description 16
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims description 16
- 239000000853 adhesive Substances 0.000 claims description 16
- 230000001070 adhesive effect Effects 0.000 claims description 16
- 239000004088 foaming agent Substances 0.000 claims description 16
- 239000003906 humectant Substances 0.000 claims description 16
- 239000002562 thickening agent Substances 0.000 claims description 16
- 238000007710 freezing Methods 0.000 claims description 14
- 230000008014 freezing Effects 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000011259 mixed solution Substances 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 240000007551 Boswellia serrata Species 0.000 claims description 12
- 230000003385 bacteriostatic effect Effects 0.000 claims description 11
- 239000008367 deionised water Substances 0.000 claims description 11
- 229910021641 deionized water Inorganic materials 0.000 claims description 11
- 235000003599 food sweetener Nutrition 0.000 claims description 11
- 239000003765 sweetening agent Substances 0.000 claims description 11
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 7
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 7
- 239000004863 Frankincense Substances 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 239000011347 resin Substances 0.000 claims description 7
- 229920005989 resin Polymers 0.000 claims description 7
- 238000009849 vacuum degassing Methods 0.000 claims description 7
- 239000003082 abrasive agent Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims 1
- 210000000170 cell membrane Anatomy 0.000 abstract description 4
- 230000000593 degrading effect Effects 0.000 abstract description 2
- 210000002200 mouth mucosa Anatomy 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 5
- 235000018062 Boswellia Nutrition 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 5
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 239000000661 sodium alginate Substances 0.000 description 5
- 235000010413 sodium alginate Nutrition 0.000 description 5
- 229940005550 sodium alginate Drugs 0.000 description 5
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- 239000000811 xylitol Substances 0.000 description 5
- 235000010447 xylitol Nutrition 0.000 description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 5
- 229960002675 xylitol Drugs 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000008029 eradication Effects 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229940079905 intestinal adsorbents bismuth preparations Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010061968 Gastric neoplasm Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 241000544066 Stevia Species 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
Abstract
本发明公开了杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法，包括以下质量份的原料：溶菌酶1‑1.5份、乳铁蛋白0.5‑2.5份、乳香提取物0.5‑2份、墨旱莲提取物0.5‑2份、小柴胡提取物0.5‑2份、苦参提取物0.5‑2份、板蓝根提取物0.5‑2份、连翘提取物0.5‑2份、甘草提取物0.5‑2份、百部素提取物0.5‑2份、白花蛇舌草提取物0.5‑2份、芦荟提取物0.5‑2份、菊花提取物0.5‑2份、甜叶菊提取物0.5‑2份、白芨提取物0.5‑2份和氨基己酸0.772.30份，其余为牙膏体基质。本发明提供的可杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，口腔抑菌膏具有强效的溶菌酶和乳香油，对溶降解幽门螺旋杆菌细胞膜，降低其与口腔粘膜的附着性而起到强效杀灭幽门螺杆菌。
Description
技术领域
本发明涉及生物化工相关技术领域，具体是杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法。
背景技术
幽门螺杆菌是公认的致病菌，被世界卫生组织列为一级致癌物(最高级，对人类为确定致癌)。与胃病(胃炎，溃疡，胃瘤，胃癌)密切相关。一旦感染幽门螺杆菌后，胃癌得病风险增加了多倍。
如何有效的治疗或预防幽门螺杆菌，对预防和控制胃癌具有重大意义。
目前，幽门螺杆菌的防治是一个世界性难题，权威推荐疗法(抗生素+铋制剂+抑酸剂)也只有70％左右的根除率，而且随着幽门螺杆菌耐药率逐年攀升，幽门螺杆菌根除率逐年下降；并且抗生素+铋制剂+抑酸剂的疗法副作用大。
鉴于全球差不多半数人口感染幽门螺杆菌、幽门螺杆菌耐药性的攀升、幽门螺杆菌根除率的下降的现实。
目前市售常见的牙膏、口腔抑菌膏、牙粉、漱口水、牙凝胶等口腔护理类产品大多数使用合成化学药物做杀灭抗抑菌成分，长期使用合成抗菌剂对人体存在潜在的危害和安全问题，市场上虽然已有一些中草药类型的口腔护理用品，但抗抑菌效果也不够理想，更别说具有杀灭幽门螺旋杆菌的作用。因此，急需一种解决现有问题的高效防控幽门螺旋杆菌口腔抑菌膏。
发明内容
本发明的目的在于提供杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的，本发明提供如下技术方案：
杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，包括以下质量份的原料：溶菌酶1-1.5份、乳铁蛋白0.5-2.5份、乳香提取物0.5-2份、墨旱莲提取物0.5-2份、小柴胡提取物0.5-2份、苦参提取物0.5-2份、板蓝根提取物0.5-2份、连翘提取物0.5-2份、甘草提取物0.5-2份、百部素提取物0.5-2份、白花蛇舌草提取物0.5-2份、芦荟提取物0.5-2份、菊花提取物0.5-2份、甜叶菊提取物0.5-2份、白芨提取物0.5-2份和氨基己酸0.772.30份，其余为牙膏体基质。
作为本发明进一步的方案：所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏包括以下质量份的原料：溶菌酶1.2-1.4份、乳铁蛋白0.8-1.6份、乳香提取物0.8-1.6份、墨旱莲提取物0.8-1.6份、小柴胡提取物0.8-1.6份、苦参提取物0.8-1.6份、板蓝根提取物0.8-1.6份、连翘提取物0.8-1.6份、甘草提取物0.8-1.6份、百部素提取物0.8-1.6份、白花蛇舌草提取物0.8-1.6份、芦荟提取物0.8-1.6份、菊花提取物0.8-1.6份、甜叶菊提取物0.8-1.6份、白芨提取物0.8-1.6份和氨基己酸1.2-2.1份，其余为牙膏体基质。
作为本发明进一步的方案：所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏包括以下质量份的原料：溶菌酶1.3份、乳铁蛋白1.2份、乳香提取物1.2份、墨旱莲提取物1.2份、小柴胡提取物1.2份、苦参提取物1.2份、板蓝根提取物1.2份、连翘提取物1.2份、甘草提取物1.2份、百部素提取物1.2份、白花蛇舌草提取物1.2份、芦荟提取物1.2份、菊花提取物1.2份、甜叶菊提取物1.2份、白芨提取物1.2份和氨基己酸1.8份，其余为牙膏体基质。
作为本发明进一步的方案：所述牙膏体基质包括以下质量份的原料：摩擦剂5-25份、保湿剂10-30份、发泡剂1.5-3份、增稠剂0.3-15份、粘合剂0.3-15份、甜味剂0.5-2份、去离子水50-60份。
所述牙膏体基质包括以下质量份的原料：摩擦剂10-20份、保湿剂15-25份、发泡剂1.7-2.6份、增稠剂6-12份、粘合剂6-12份、甜味剂1-1.7份、去离子水52-57份。
所述牙膏体基质包括以下质量份的原料：摩擦剂15份、保湿剂20份、发泡剂2.3份、增稠剂9份、粘合剂9份、甜味剂1.5份、去离子水55份。
杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏的制备方法，包括以下步骤：
S1、将溶菌酶、乳铁蛋白、乳香提取物、墨旱莲提取物、小柴胡提取物、苦参提取物、板蓝根提取物、连翘提取物、甘草提取物、百部素提取物、白花蛇舌草提取物、芦荟提取物、菊花提取物、甜叶菊提取物、白芨提取物和氨基己酸加入到搅拌罐中进行搅拌得到混合液；
S2、将上述混合液加入到真空制膏机中，随后加入牙膏体基质进行搅拌、真空脱气、灌装。
作为本发明进一步的方案：所述乳香提取物的制备方法，包括以下步骤：
S11、将乳香树脂依次经过干燥、冷冻、粉碎和加热后获得乳香液；将乳香树树脂在-12℃条件下冷冻6h后粉碎，并慢速加热至75℃得乳香液；
S12、将乳香液加入1：10蒸馏水进行搅拌，搅拌后采用回流提取法加热，然后经过二次回流滤渣，最后浓缩获得乳香提取物。
与现有技术相比，本发明的有益效果是：本发明提供的可杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，口腔抑菌膏具有强效的溶菌酶和乳香油，对溶降解幽门螺旋杆菌细胞膜，降低其与口腔粘膜的附着性而起到强效杀灭幽门螺杆菌。
2、长效的乳铁蛋白可促进双歧杆菌增生，双歧杆菌是革兰氏阳性菌能有效抑制幽门螺旋杆菌的生长，通过残留在牙齿间的乳铁蛋白，不断促进益生菌双歧杆菌的生长从而达到保持口腔内强效与长效相结合的口腔内幽门螺旋杆菌杀灭效果。
3、本发明所述的可杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，二种功效抑制幽门螺旋杆菌细胞作用，起到相互强效与长效相结合，能有效预防幽门螺旋杆菌滋生，可强效杀灭和长效抑制口腔幽门螺杆菌，效去除口腔异味、牙菌斑、牙结石、改善牙龈肿痛出血、口腔溃疡、预防牙周炎且能强健牙质，保持口腔的卫生健康，起到杜绝幽门螺旋杆菌进入胃部的防火墙。
具体实施方式
下面将结合本发明实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
本发明实施例中，杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，包括以下质量份的原料：溶菌酶1份、乳铁蛋白0.5份、乳香提取物0.5份、墨旱莲提取物0.5份、小柴胡提取物0.5份、苦参提取物0.5份、板蓝根提取物0.5份、连翘提取物0.5份、甘草提取物0.5份、百部素提取物0.5份、白花蛇舌草提取物0.5份、芦荟提取物0.5份、菊花提取物0.5份、甜叶菊提取物0.5份、白芨提取物0.5份和氨基己酸0.77份，其余为牙膏体基质。
在本发明的实施例中，所述牙膏体基质包括以下质量份的原料：摩擦剂5-25份、保湿剂10份、发泡剂1.5份、增稠剂0.3份、粘合剂0.3份、甜味剂0.5份、去离子水50份。
在本发明实施例中，所述摩擦剂为二氧化硅或/和磷酸氢钙；所述发泡剂为十二烷基硫酯钠或/和椰油酰基谷氨酸钠；所述保湿剂为木糖醇或/和甘油及山梨糖醇；所述增稠剂为黄原胶或/和海藻酸钠；所述粘合剂为羧甲基纤维。
所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏的制备方法，具体制备步骤为：
S1、将溶菌酶、乳铁蛋白、乳香提取物、墨旱莲提取物、小柴胡提取物、苦参提取物、板蓝根提取物、连翘提取物、甘草提取物、百部素提取物、白花蛇舌草提取物、芦荟提取物、菊花提取物、甜叶菊提取物、白芨提取物和氨基己酸加入到搅拌罐中进行搅拌得到混合液；
S2、将上述混合液加入到真空制膏机中，随后加入牙膏体基质进行搅拌、真空脱气、灌装。
在本发明的实施例中，所述乳香提取物的制备方法，包括以下步骤：
S11、将乳香树脂依次经过干燥、冷冻、粉碎和加热后获得乳香液；将乳香树树脂在-12℃条件下冷冻6h后粉碎，并慢速加热至75℃得乳香液；
S12、将乳香液加入1：10蒸馏水进行搅拌，搅拌后采用回流提取法加热，然后经过二次回流滤渣，最后浓缩获得乳香提取物。
实施例2
本发明实施例中，杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，包括以下质量份的原料：溶菌酶1.2份、乳铁蛋白0.8份、乳香提取物0.8份、墨旱莲提取物0.8份、小柴胡提取物0.8份、苦参提取物0.8份、板蓝根提取物0.8份、连翘提取物0.8份、甘草提取物0.8份、百部素提取物0.8份、白花蛇舌草提取物0.8份、芦荟提取物0.8份、菊花提取物0.8份、甜叶菊提取物0.8份、白芨提取物0.8份和氨基己酸1.2份，其余为牙膏体基质。
在本发明的实施例中，所述牙膏体基质包括以下质量份的原料：摩擦剂10份、保湿剂15份、发泡剂1.7份、增稠剂6份、粘合剂6份、甜味剂1份、去离子水52份。
在本发明实施例中，所述摩擦剂为二氧化硅或/和磷酸氢钙；所述发泡剂为十二烷基硫酯钠或/和椰油酰基谷氨酸钠；所述保湿剂为木糖醇或/和甘油及山梨糖醇；所述增稠剂为黄原胶或/和海藻酸钠；所述粘合剂为羧甲基纤维。
所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏的制备方法，具体制备步骤为：
S1、将溶菌酶、乳铁蛋白、乳香提取物、墨旱莲提取物、小柴胡提取物、苦参提取物、板蓝根提取物、连翘提取物、甘草提取物、百部素提取物、白花蛇舌草提取物、芦荟提取物、菊花提取物、甜叶菊提取物、白芨提取物和氨基己酸加入到搅拌罐中进行搅拌得到混合液；
S2、将上述混合液加入到真空制膏机中，随后加入牙膏体基质进行搅拌、真空脱气、灌装。
在本发明的实施例中，所述乳香提取物的制备方法，包括以下步骤：
S11、将乳香树脂依次经过干燥、冷冻、粉碎和加热后获得乳香液；将乳香树树脂在-12℃条件下冷冻6h后粉碎，并慢速加热至75℃得乳香液；
S12、将乳香液加入1：10蒸馏水进行搅拌，搅拌后采用回流提取法加热，然后经过二次回流滤渣，最后浓缩获得乳香提取物。
实施例3
本发明实施例中，杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，包括以下质量份的原料：溶菌酶1.3份、乳铁蛋白1.2份、乳香提取物1.2份、墨旱莲提取物1.2份、小柴胡提取物1.2份、苦参提取物1.2份、板蓝根提取物1.2份、连翘提取物1.2份、甘草提取物1.2份、百部素提取物1.2份、白花蛇舌草提取物1.2份、芦荟提取物1.2份、菊花提取物1.2份、甜叶菊提取物1.2份、白芨提取物1.2份和氨基己酸1.8份，其余为牙膏体基质。
在本发明的实施例中，所述牙膏体基质包括以下质量份的原料：摩擦剂15份、保湿剂20份、发泡剂2.3份、增稠剂9份、粘合剂9份、甜味剂1.5份、去离子水55份。
在本发明实施例中，所述摩擦剂为二氧化硅或/和磷酸氢钙；所述发泡剂为十二烷基硫酯钠或/和椰油酰基谷氨酸钠；所述保湿剂为木糖醇或/和甘油及山梨糖醇；所述增稠剂为黄原胶或/和海藻酸钠；所述粘合剂为羧甲基纤维。
所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏的制备方法，具体制备步骤为：
S1、将溶菌酶、乳铁蛋白、乳香提取物、墨旱莲提取物、小柴胡提取物、苦参提取物、板蓝根提取物、连翘提取物、甘草提取物、百部素提取物、白花蛇舌草提取物、芦荟提取物、菊花提取物、甜叶菊提取物、白芨提取物和氨基己酸加入到搅拌罐中进行搅拌得到混合液；
S2、将上述混合液加入到真空制膏机中，随后加入牙膏体基质进行搅拌、真空脱气、灌装。
在本发明的实施例中，所述乳香提取物的制备方法，包括以下步骤：
S11、将乳香树脂依次经过干燥、冷冻、粉碎和加热后获得乳香液；将乳香树树脂在-12℃条件下冷冻6h后粉碎，并慢速加热至75℃得乳香液；
S12、将乳香液加入1：10蒸馏水进行搅拌，搅拌后采用回流提取法加热，然后经过二次回流滤渣，最后浓缩获得乳香提取物。
实施例4
本发明实施例中，杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，包括以下质量份的原料：溶菌酶1.4份、乳铁蛋白1.6份、乳香提取物1.6份、墨旱莲提取物1.6份、小柴胡提取物1.6份、苦参提取物1.6份、板蓝根提取物1.6份、连翘提取物1.6份、甘草提取物1.6份、百部素提取物1.6份、白花蛇舌草提取物1.6份、芦荟提取物1.6份、菊花提取物1.6份、甜叶菊提取物1.6份、白芨提取物1.6份和氨基己酸2.1份，其余为牙膏体基质。
在本发明的实施例中，所述牙膏体基质包括以下质量份的原料：摩擦剂20份、保湿剂25份、发泡剂2.6份、增稠剂12份、粘合剂12份、甜味剂1.7份、去离子水57份。
在本发明实施例中，所述摩擦剂为二氧化硅或/和磷酸氢钙；所述发泡剂为十二烷基硫酯钠或/和椰油酰基谷氨酸钠；所述保湿剂为木糖醇或/和甘油及山梨糖醇；所述增稠剂为黄原胶或/和海藻酸钠；所述粘合剂为羧甲基纤维。
所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏的制备方法，具体制备步骤为：
S1、将溶菌酶、乳铁蛋白、乳香提取物、墨旱莲提取物、小柴胡提取物、苦参提取物、板蓝根提取物、连翘提取物、甘草提取物、百部素提取物、白花蛇舌草提取物、芦荟提取物、菊花提取物、甜叶菊提取物、白芨提取物和氨基己酸加入到搅拌罐中进行搅拌得到混合液；
S2、将上述混合液加入到真空制膏机中，随后加入牙膏体基质进行搅拌、真空脱气、灌装。
在本发明的实施例中，所述乳香提取物的制备方法，包括以下步骤：
S11、将乳香树脂依次经过干燥、冷冻、粉碎和加热后获得乳香液；将乳香树树脂在-12℃条件下冷冻6h后粉碎，并慢速加热至75℃得乳香液；
S12、将乳香液加入1：10蒸馏水进行搅拌，搅拌后采用回流提取法加热，然后经过二次回流滤渣，最后浓缩获得乳香提取物。
实施例5
本发明实施例中，杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，包括以下质量份的原料：溶菌酶1.5份、乳铁蛋白2.5份、乳香提取物2份、墨旱莲提取物2份、小柴胡提取物2份、苦参提取物2份、板蓝根提取物2份、连翘提取物2份、甘草提取物2份、百部素提取物2份、白花蛇舌草提取物2份、芦荟提取物2份、菊花提取物2份、甜叶菊提取物2份、白芨提取物2份和氨基己酸2.30份，其余为牙膏体基质。
在本发明的实施例中，所述牙膏体基质包括以下质量份的原料：摩擦剂25份、保湿剂30份、发泡剂3份、增稠剂15份、粘合剂15份、甜味剂2份、去离子水60份。
在本发明实施例中，所述摩擦剂为二氧化硅或/和磷酸氢钙；所述发泡剂为十二烷基硫酯钠或/和椰油酰基谷氨酸钠；所述保湿剂为木糖醇或/和甘油及山梨糖醇；所述增稠剂为黄原胶或/和海藻酸钠；所述粘合剂为羧甲基纤维。
所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏的制备方法，具体制备步骤为：
S1、将溶菌酶、乳铁蛋白、乳香提取物、墨旱莲提取物、小柴胡提取物、苦参提取物、板蓝根提取物、连翘提取物、甘草提取物、百部素提取物、白花蛇舌草提取物、芦荟提取物、菊花提取物、甜叶菊提取物、白芨提取物和氨基己酸加入到搅拌罐中进行搅拌得到混合液；
S2、将上述混合液加入到真空制膏机中，随后加入牙膏体基质进行搅拌、真空脱气、灌装。
在本发明的实施例中，所述乳香提取物的制备方法，包括以下步骤：
S11、将乳香树脂依次经过干燥、冷冻、粉碎和加热后获得乳香液；将乳香树树脂在-12℃条件下冷冻6h后粉碎，并慢速加热至75℃得乳香液；
S12、将乳香液加入1：10蒸馏水进行搅拌，搅拌后采用回流提取法加热，然后经过二次回流滤渣，最后浓缩获得乳香提取物。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外，应当理解，虽然本说明书按照实施方式加以描述，但并非每个实施方式仅包含一个独立的技术方案，说明书的这种叙述方式仅仅是为清楚起见，本领域技术人员应当将说明书作为一个整体，各实施例中的技术方案也可以经适当组合，形成本领域技术人员可以理解的其他实施方式。
Claims (8)
1.杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，其特征在于，包括以下质量份的原料：溶菌酶1-1.5份、乳铁蛋白0.5-2.5份、乳香提取物0.5-2份、墨旱莲提取物0.5-2份、小柴胡提取物0.5-2份、苦参提取物0.5-2份、板蓝根提取物0.5-2份、连翘提取物0.5-2份、甘草提取物0.5-2份、百部素提取物0.5-2份、白花蛇舌草提取物0.5-2份、芦荟提取物0.5-2份、菊花提取物0.5-2份、甜叶菊提取物0.5-2份、白芨提取物0.5-2份和氨基己酸0.772.30份，其余为牙膏体基质。
2.根据权利要求1所述的杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，其特征在于，所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏包括以下质量份的原料：溶菌酶1.2-1.4份、乳铁蛋白0.8-1.6份、乳香提取物0.8-1.6份、墨旱莲提取物0.8-1.6份、小柴胡提取物0.8-1.6份、苦参提取物0.8-1.6份、板蓝根提取物0.8-1.6份、连翘提取物0.8-1.6份、甘草提取物0.8-1.6份、百部素提取物0.8-1.6份、白花蛇舌草提取物0.8-1.6份、芦荟提取物0.8-1.6份、菊花提取物0.8-1.6份、甜叶菊提取物0.8-1.6份、白芨提取物0.8-1.6份和氨基己酸1.2-2.1份，其余为牙膏体基质。
3.根据权利要求2所述的杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，其特征在于，所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏包括以下质量份的原料：溶菌酶1.3份、乳铁蛋白1.2份、乳香提取物1.2份、墨旱莲提取物1.2份、小柴胡提取物1.2份、苦参提取物1.2份、板蓝根提取物1.2份、连翘提取物1.2份、甘草提取物1.2份、百部素提取物1.2份、白花蛇舌草提取物1.2份、芦荟提取物1.2份、菊花提取物1.2份、甜叶菊提取物1.2份、白芨提取物1.2份和氨基己酸1.8份，其余为牙膏体基质。
4.根据权利要求1-3任意一项所述的杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，其特征在于，所述牙膏体基质包括以下质量份的原料：摩擦剂5-25份、保湿剂10-30份、发泡剂1.5-3份、增稠剂0.3-15份、粘合剂0.3-15份、甜味剂0.5-2份、去离子水50-60份。
5.根据权利要求4所述的杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，其特征在于，所述牙膏体基质包括以下质量份的原料：摩擦剂10-20份、保湿剂15-25份、发泡剂1.7-2.6份、增稠剂6-12份、粘合剂6-12份、甜味剂1-1.7份、去离子水52-57份。
6.根据权利要求5所述的杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏，其特征在于，所述牙膏体基质包括以下质量份的原料：摩擦剂15份、保湿剂20份、发泡剂2.3份、增稠剂9份、粘合剂9份、甜味剂1.5份、去离子水55份。
7.如权利要求1-6任意一项所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏的制备方法，其特征在于，包括以下步骤：
S1、将溶菌酶、乳铁蛋白、乳香提取物、墨旱莲提取物、小柴胡提取物、苦参提取物、板蓝根提取物、连翘提取物、甘草提取物、百部素提取物、白花蛇舌草提取物、芦荟提取物、菊花提取物、甜叶菊提取物、白芨提取物和氨基己酸加入到搅拌罐中进行搅拌得到混合液；
S2、将上述混合液加入到真空制膏机中，随后加入牙膏体基质进行搅拌、真空脱气、灌装。
8.根据权利要求7所述杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏的制备方法，其特征在于，所述乳香提取物的制备方法，包括以下步骤：
S11、将乳香树脂依次经过干燥、冷冻、粉碎和加热后获得乳香液；将乳香树树脂在-12℃条件下冷冻6h后粉碎，并慢速加热至75℃得乳香液；
S12、将乳香液加入1：10蒸馏水进行搅拌，搅拌后采用回流提取法加热，然后经过二次回流滤渣，最后浓缩获得乳香提取物。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010672273.6A CN111714625A (zh) | 2020-07-14 | 2020-07-14 | 杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010672273.6A CN111714625A (zh) | 2020-07-14 | 2020-07-14 | 杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111714625A true CN111714625A (zh) | 2020-09-29 |
Family
ID=72572440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010672273.6A Pending CN111714625A (zh) | 2020-07-14 | 2020-07-14 | 杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111714625A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112316123A (zh) * | 2020-12-03 | 2021-02-05 | 滁州向日葵药业有限公司 | 一种抗幽门螺杆菌感染的中药组合物及其制备方法与应用 |
| CN112494401A (zh) * | 2020-12-17 | 2021-03-16 | 江门市金本士贸易有限公司 | 一种祛黄洁白抗幽门螺旋杆菌的抑菌中药牙膏 |
| CN112545978A (zh) * | 2020-12-15 | 2021-03-26 | 上海利康消毒高科技有限公司 | 具有持效抗幽门螺杆菌作用的口腔护理凝胶及其制备方法 |
| CN116076736A (zh) * | 2023-04-07 | 2023-05-09 | 北京东方红航天生物技术股份有限公司 | 一种抗幽养胃组合物及其应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109125144A (zh) * | 2018-11-01 | 2019-01-04 | 长春健康未来医药科技有限公司 | 一种预防口腔溃疡、抑制幽门螺旋杆菌的牙膏及其制法 |
| CN109806222A (zh) * | 2019-03-22 | 2019-05-28 | 姜集大 | 一种用于抑制幽门螺杆菌的牙膏及其制备方法 |
| CN110522670A (zh) * | 2019-09-21 | 2019-12-03 | 广州市可优美科技有限公司 | 一种长效抗幽门螺杆菌牙膏 |
| CN111249399A (zh) * | 2020-04-01 | 2020-06-09 | 森淼科技(嘉兴)有限公司 | 一种口腔hp抑菌膏及其生产工艺 |
-
2020
- 2020-07-14 CN CN202010672273.6A patent/CN111714625A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109125144A (zh) * | 2018-11-01 | 2019-01-04 | 长春健康未来医药科技有限公司 | 一种预防口腔溃疡、抑制幽门螺旋杆菌的牙膏及其制法 |
| CN109806222A (zh) * | 2019-03-22 | 2019-05-28 | 姜集大 | 一种用于抑制幽门螺杆菌的牙膏及其制备方法 |
| CN110522670A (zh) * | 2019-09-21 | 2019-12-03 | 广州市可优美科技有限公司 | 一种长效抗幽门螺杆菌牙膏 |
| CN111249399A (zh) * | 2020-04-01 | 2020-06-09 | 森淼科技(嘉兴)有限公司 | 一种口腔hp抑菌膏及其生产工艺 |
Non-Patent Citations (1)
| Title |
|---|
| 王厚伟等: "基于计算机编程的抗菌中药性效分析", 《辽宁中医杂志》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112316123A (zh) * | 2020-12-03 | 2021-02-05 | 滁州向日葵药业有限公司 | 一种抗幽门螺杆菌感染的中药组合物及其制备方法与应用 |
| CN112545978A (zh) * | 2020-12-15 | 2021-03-26 | 上海利康消毒高科技有限公司 | 具有持效抗幽门螺杆菌作用的口腔护理凝胶及其制备方法 |
| CN112494401A (zh) * | 2020-12-17 | 2021-03-16 | 江门市金本士贸易有限公司 | 一种祛黄洁白抗幽门螺旋杆菌的抑菌中药牙膏 |
| CN116076736A (zh) * | 2023-04-07 | 2023-05-09 | 北京东方红航天生物技术股份有限公司 | 一种抗幽养胃组合物及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111714625A (zh) | 杀灭或抑制口腔内幽门螺旋杆菌的抑菌膏及其制备方法 | |
| US20100303737A1 (en) | Tooth-Cleaning Formulation | |
| JP2004083443A (ja) | マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法 | |
| CN102639100A (zh) | 用于口腔卫生和治疗微生物起源的口腔疾病的抗菌药物组合物 | |
| JPH0776510A (ja) | 竹塩を含有する口腔衛生増進用組成物 | |
| CN111249399A (zh) | 一种口腔hp抑菌膏及其生产工艺 | |
| KR101641213B1 (ko) | 상백피추출물과 화살나무추출물을 유효성분으로 포함하는 치주염 예방 및 치료용 구강조성물 | |
| CN108938501A (zh) | 应用于口腔护理产品的中药组合物及口腔护理产品 | |
| CN101756819A (zh) | 一种柠檬漱口水及其制备方法 | |
| CN103908423B (zh) | 抗口腔幽门螺杆菌中药牙膏 | |
| CN101756820A (zh) | 一种绿茶漱口水及其制备方法 | |
| CN101181293A (zh) | 一种口腔保健防龋齿含片 | |
| KR101641215B1 (ko) | 상백피추출물과 화살나무추출물을 유효성분으로 포함하는 충치 예방 및 치료용 구강조성물 | |
| CN104983744A (zh) | 含美洲大蠊的口腔护理组合物、口腔用品及制备方法 | |
| CN103599182A (zh) | 中药组合物及其制备方法、口腔清洁护理用品及其制备方法 | |
| JP3389556B2 (ja) | 歯周病予防又は治療用組成物 | |
| KR20200030230A (ko) | 해죽순 추출물을 유효성분으로 포함하는 구강용 조성물 | |
| CN113318057B (zh) | 一种老年人护理牙膏及其制备方法与应用 | |
| CN108743442A (zh) | 薁磺酸钠、西吡氯铵和锌离子复合配方漱口水及制备方法 | |
| CN112076221B (zh) | 一种脱敏糊剂及其制备方法和用途 | |
| CN105213216B (zh) | 一种天然双糖抗菌护齿漱口液及其制备方法 | |
| KR101910716B1 (ko) | 녹차 함유 구강세척제 | |
| KR102182965B1 (ko) | 천연 추출물을 함유하는 치약 조성물 | |
| CN112294872B (zh) | 有助于宠物口腔清洁的药物组合物及其制备方法 | |
| TWI730287B (zh) | 口腔用組合物及其製備方法與用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200929 |